サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1623294

経頚管卵管不妊法の世界市場規模：製品別、用途別、地域別、範囲および予測

Global Transcervical Tubal Sterilization Market Size By Product(tubal ligation and transcervical implants), By Application(hospitals, clinics, and others), and Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
経頚管卵管不妊法の世界市場規模：製品別、用途別、地域別、範囲および予測
出版日: 2024年07月21日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経頚管卵管不妊法の市場規模および予測

経頚管卵管不妊法の市場規模は、ここ数年大幅な成長率で急成長しており、2021年から2028年の予測期間において、市場は大きく成長すると予測されます。

経頚管卵管不妊法市場の成長は、ライフスタイルの変化、認知度の向上、避妊技術、可処分所得の増加によってもたらされます。経頚管卵管不妊法の世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

経頚管卵管不妊法の世界市場定義

不妊手術は、永久避妊の方法として選択されることが多いです。従来の方法では、手術室での麻酔下での手術が必要であり、回復期間や傷跡が伴います。経子宮頸管的不妊手術または卵管閉塞術は、外科的卵管結紮術に代わる、切開を伴わない低侵襲手術です。腹腔鏡手術と比較すると、経頸管的子宮鏡下避妊術は手術室で行う必要がなく、麻酔も少なくて済み、回復期間も短く、費用対効果も高いです。

経頚管卵管不妊法は、卵管へのアクセスが良好で、閉塞率が高く、患者の受容性が高く、外来患者環境で行われます。このような要素の組み合わせは、従来の腹腔鏡アプローチに大きな利点をもたらし、費用対効果も高くなると考えられます。

経頚管卵管不妊法の世界市場概要

世界中で避妊に対する意識が高まっていることが、市場の成長を後押しすると予想されます。市場を牽引する重要な要因は、このプロセスが避妊薬のような副作用を示さず、最も安全な避妊方法であることです。さらに、不妊手術の手順を強化するための様々な市場プレーヤーによる技術的進歩や、現在行われている市場プレーヤーによる啓発活動は、女性に提供されている経子宮頸管的不妊手術の操作の絶え間ない向上と質の改善に焦点を当てています。さらに、この手術には切開が必要ないため、オフィスで行うことができます。従って、コストと時間効率が高く、麻酔の必要性が最小からゼロであり、広範囲に骨盤の癒着がある女性でも行うことができ、術後の痛みが少なく、腹腔鏡検査や開腹手術を妨げる併存疾患を持つ女性でも完了することができ、予測期間中の経子宮頸管的不妊化世界市場の成長の原因となっています。

合併症のリスクや長い回復期間などの要因は、市場の成長にマイナスの影響を与える可能性のある課題です。さらに、プロセスなどの要素は不可逆的です。これは永久的な方法であり、一部の変更のみが可逆的であるため、性感染症に対する保護がないことが市場の成長を抑制する要因となっています。処置後12週間（卵管閉塞が確認されるまで）は避妊が必要であること、卵管閉塞を確認するための装置と画像検査に費用がかかること、マイクロインサートの導電性により、その後の骨盤内処置での電気メスの使用が制限されること、片側卵管閉塞のリスクが高いこと、潜在的合併症を最小限に抑えるために適切な膣手術トレーニングが必要であることなどが、世界の経頸管的避妊手術市場を阻害する要因です。

家族計画に対する意識の高まりと、性病のリスクを軽減する経頚管卵管不妊法に関わる新技術の進歩は、予測期間内に新たな機会を生み出すかもしれないです。

目次

第1章 経頚管卵管不妊法の世界市場：イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 経頚管卵管不妊法の世界市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターファイブフォースモデル
  • バリューチェーン分析

第5章 経頚管卵管不妊法の世界市場：製品別

  • 概要
  • 卵管結紮術
  • 経頸管インプラント

第6章 経頚管卵管不妊法の世界市場：用途別

  • 概要
  • 病院
  • クリニック
  • その他

第7章 経頚管卵管不妊法の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • 中東・アフリカ
    • ラテンアメリカ

第8章 経頚管卵管不妊法の世界市場：競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展戦略

第9章 企業プロファイル

  • Ethicon
  • Medtronic
  • Applied Medical
  • Richard Wolf
  • Bayer AG
  • Stryker
  • LiNA Medical
  • ConMed
  • Microline Surgical
  • Apollo Endosurgery

第10章 付録

  • 関連調査
目次
Product Code: 21654

Transcervical Tubal Sterilization Market Size And Forecast

Transcervical Tubal Sterilization Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e., 2021 to 2028.

The transcervical Tubal sterilization market growth is driven by changing lifestyles, increased awareness, birth control techniques, and increased disposable income. The Global Transcervical Tubal Sterilization Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Transcervical Tubal Sterilization Market Definition

Sterilization is often chosen as a method of permanent contraception. Traditional approaches involve surgery under anesthesia in an operating room and are associated with a recovery period and scars. Transcervical sterilization or tubal occlusion is an incision-free, minimally invasive procedure alternative to surgical tubal ligation. Compared with laparoscopic surgery, transcervical hysteroscopic sterilization does not need to be performed in an operating room, requires less anesthesia, has a shorter recovery period, and is more cost-effective.

Transcervical tubal sterilization methods have good tubal access, occlusion rates, high patient acceptability and are performed in an outpatient environment. This combination of factors may offer significant benefits to traditional laparoscopic approaches and render them more cost-effective.

Global Transcervical Tubal Sterilization Market Overview

The growing awareness for birth control across the globe is expected to boost the growth of the market. The primary factor that plays a significant role in driving the market is that this process does not show any side effects that consist of birth control pills and is the safest contraceptive method. Further, the technological advancements by the various market players to enhance the procedure of sterilization and the awareness drives by the market players currently done are focused on constant up-gradation and improvement of the quality of operation of Transcervical Tubal Sterilization being provided to the women. Moreover, the factor such as there's no incision involved in the procedure can be performed in an office setting. Hence, it is more cost- and time-effective, has Minimal to no anesthetic requirements, can be performed in women with extensive pelvic adhesions, causes Less post-operative pain, it can be completed in women with co-morbidities that preclude laparoscopy or laparotomy are responsible for the growth of Global Transcervical Tubal Sterilization Market during the forecast period.

The factors such as the risk of complications and long recovery period are challenges that may negatively impact the market's growth. Moreover, the element such as process is irreversible. It is a permanent method, and only a few changes are reversible-the absence of protection against sexually transmitted diseases restraint the market's growth. Need for contraception for 12 weeks post-procedure (until the tubal occlusion is confirmed); The expense of device and imaging study to ensure tubal occlusion; Electrical conductivity of micro-insert limits the use of electrocautery during subsequent pelvic procedures; Higher risk of unilateral tubal occlusion; The need for adequate vaginal surgical training to minimize potential complications are some additional factors that can hinder the global transcervical tubal sterilization market.

The growing awareness about family planning and the advancement of new technologies involved in Transcervical Tubal Sterilization that reduce the risk of STDs might generate new opportunities within the forecast period.

Global Transcervical Tubal Sterilization Market: Segmentation Analysis

The Global Transcervical Tubal Sterilization Market is segmented based on Product, Application, and Geography.

Transcervical Tubal Sterilization Market by Product

  • Tubal Ligation
  • Transcervical Implants

Based on the product, the global transcervical tubal sterilization market is bifurcated into tubal ligation and transcervical implants. Tubal ligation dominates this segment of the global transcervical tubal sterilization market, owing to governments' sponsorship to control the country's populations. This kind of female sterilization needs a laparoscopic incision to be made in the abdominal area to surgically block the fallopian tubes by cutting, tying, or using clamps. This kind of sterilization procedure is effective immediately. The transcervical implant segment is expected to witness steady growth in the forecasted period. As one of the main factors for the development of the market, this procedure involves no surgical incision and hence can be performed in an office setting.

Transcervical Tubal Sterilization Market by Application

  • Hospitals
  • Clinics
  • Others

Based on application, the global transcervical tubal sterilization market is bifurcated into hospitals, clinics, and others. Hospitals dominate this segment owing to prefer in emerging countries not able to afford treatment in clinics that are usually privately managed though clinics are witnessing a steady rise in the global transcervical tubal sterilization market. Moreover, most clinics do not offer such procedures, which are available in almost all of the hospitals everywhere. The presence of clinics is also a factor why the hospital's segment has the majority share in this segment; the number of hospitals is enormous compared to the number of hospitals.

Transcervical Tubal Sterilization Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on geography, the global transcervical tubal sterilization market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the world. North American market leads the transcervical tubal sterilization market in terms of revenue share, owing to awareness among the general population and increasing promotion for family planning activities from the government. Europe market held the second largest market share of the global transcervical tubal sterilization market in terms of sales, followed by the market in the Asia Pacific.

Key Players

The "Global Transcervical Tubal Sterilization Market" study report will provide valuable insight emphasizing the global market. The major players in the market are

Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the players mentioned above globally.

Report Scope

Report Attributes

Report Attributes

Study Period

2017-2028

Base Year

2020

Forecast Period

2021-2028

Historical Period

2017-2019

Key Companies Profiled

Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

Segments Covered

By Product, By Application, and By Geography.

Customization scope

Free report customization (equivalent up to 4 analyst's working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports

Transportation Battery Market Size And Forecast

Training Dancewear Market Size And Forecast

Global Transcervical Tubal Sterilization Market: Research Methodology

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our

sales team

Reasons to Purchase this Report:

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter's five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post sales analyst support

Customization of the Report

  • In case of any

Queries or Customization Requirements

Frequently Asked Questions

What are the key driving factors for the growth of the Transcervical Tubal Sterilization Market?

  • The transcervical Tubal sterilization market growth is driven by changing lifestyles, increased awareness, birth control techniques, and increased disposable income.

What are the top players operating in the Transcervical Tubal Sterilization Market?

  • Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

What segments are covered in the Transcervical Tubal Sterilization Market?

  • The Global Transcervical Tubal Sterilization Market is segmented based on Product, Application, and Geography.
  • The sample report of the Transcervical Tubal Sterilization Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porter Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY PRODUCT

  • 5.1 Overview
  • 5.2 Tubal Ligation
  • 5.3 Transcervical Implants

6 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY APPLICATION

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Clinics
  • 6.4 Others

7 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Middle East and Africa
    • 7.5.2 Latin America

8 GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Ethicon
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Medtronic
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Applied Medical
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Richard Wolf
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Bayer AG
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Stryker
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Development
  • 9.7 LiNA Medical
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 ConMed
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Microline Surgical
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Development
  • 9.10 Apollo Endosurgery
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Development

10 Appendix

  • 10.1 Related Research